NCT07508735

Brief Summary

The study aims to evaluate the bioavailability of phlorotannins and carotenoids from the seaweed Himanthalia elongata in healthy individuals after the consumption of a cracker fortified with this plant species. The study consists of an acute, blinded, randomized, controlled, crossover trial in which each participant consumes both the fortified cracker and a control cracker without seaweed. This design allows the comparison of the bioavailability of these compounds when incorporated into a bakery-based food matrix.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2026

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

15 days

First QC Date

March 5, 2026

Last Update Submit

March 30, 2026

Conditions

Keywords

carotenoidsabsortionCmaxphlorotanninsbioavailability

Outcome Measures

Primary Outcomes (1)

  • Targeted metabolic analysis of phlorotannins in blood/urine samples

    Targeted metabolomic analysis of phlorotannins in plasma and urine samples will be conducted using HPLC-QTOF-MS. Quantification of the concentration (μM) will be carried out employing authentic commercial standards, ensuring accurate and reliable measurement of target compounds.

    2 moths

Secondary Outcomes (5)

  • Targeted metabolic analysis of carotenoids in blood/urine samples.

    2 months

  • Maximum concentration in blood of metabolites

    2 month

  • Area under the curve (AUC) of metabolites in blood samples

    2 moths

  • Time to maximum concentration (Tmax)

    2 month

  • Urinary excretion percentage of metabolites

    2 months

Study Arms (2)

Seaweed cracker

EXPERIMENTAL

Rice flour, wheat flour, cornstarch, Himanthalia elongata (0.94 g), salt, sesame, mannitol, baking powder, olive oil.

Other: Seaweed cracker

Control cracker

PLACEBO COMPARATOR

Rice flour, wheat flour, cornstarch, salt, sesame, mannitol, baking powder, olive oil

Other: Control cracker

Interventions

Four crackers (20 g) fortified with seaweed Himanthalia elongata

Seaweed cracker

Four crackers (20 g) without seaweed in its composition

Control cracker

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index: 18-30 Kg/m2

You may not qualify if:

  • Following a vegetarian diet
  • Being pregnant
  • Suffering from digestive diseases (such as irritable bowel syndrome, gastrointestinal ulcers, etc.)
  • Having a history of hypersensitivity or allergies to components of the study foods
  • Following any medication regimen
  • Currently taking or having recently taken antibiotics
  • Having donated blood within the three months prior to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Food Science, Technology and Nutrition, Spanish National Research Council (ICTAN-CSIC)

Madrid, Madrid, 28040, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Acute and controlled
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific Researcher

Study Record Dates

First Submitted

March 5, 2026

First Posted

April 2, 2026

Study Start

March 1, 2026

Primary Completion

March 16, 2026

Study Completion

June 1, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations